Treatment of prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8791094
SERIAL NO

12851070

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17α-hydroxylase/C17,20-lyase such as 3-β-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOKAI PHARMACEUTICALS INCONE BROADWAY 14TH STREET CAMBRIDGE MA 01741

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Casebier, David Scott Carlisle, US 11 92
Morrison, Jodie Pope Wakefield, US 5 41
Stein, Cy Aaron New City, US 6 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 29, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00